Brown Virtual Lab
Research project management
Brown Virtual LabSite home

GLP-1 Education · 040

STEP-HFpEF: Bring Symptoms and Daily Function into the Treatment Conversation

Use patient reported outcomes thoughtfully when assessing obesity related HFpEF care.

Clinicians · October 6, 2026

Dr. Sherry-Ann Brown, MD, PhD, FACC, FAHA

Understand the outcome studied

STEP-HFpEF found improvements in symptoms, physical limitations, exercise function, and weight with semaglutide in the studied obesity and HFpEF population. These findings support attention to how patients feel and function. The implementation suggestions below are an original clinical workflow synthesis.

Describe the individual phenotype

Confirm the patient's heart failure diagnosis and relevant cardiac information. Review symptoms, current treatment, volume history, and the conditions contributing to activity limitation. Ask which daily activity matters most to the patient and how their present symptoms affect it. Verify current product labeling and assess whether treatment is appropriate within the complete clinical plan. A patient's difficulty walking may involve several contributors. Describing those contributors at baseline supports a more meaningful discussion when symptoms or activity tolerance changes later.

Measure a patient centered outcome

Choose a repeatable symptom or functional measure appropriate to the setting. A validated questionnaire may be useful when the team can apply it consistently. A clearly documented daily activity can also anchor a practical discussion. Record when and how the measure was obtained. Pair it with clinically relevant examination and monitoring. At followup, ask about the same activity or use the same tool. When function changes, assess what else changed in treatment, health, or daily circumstances. This approach makes the clinical review attentive to the outcomes that matter to the patient.

Integrate findings with heart failure care

Coordinate with the heart failure team concerning symptoms, volume assessment, and other medication decisions. Explain the trial's studied outcomes and the limits of individual prediction. Document the patient's priorities, evidence considered, treatment decision, and followup plan. If symptom improvement occurs, evaluate it within the wider clinical picture. If symptoms worsen, reassess promptly. A structured conversation connects research to daily experience while preserving the role of comprehensive heart failure management and careful evaluation of new clinical findings.

Choose a measure the team can repeat

A symptom questionnaire requires a consistent collection method and interpretation. A daily activity description requires enough detail to be comparable later: distance, frequency, associated symptoms, and recovery. Decide which approach the practice can sustain. Record contextual changes such as rehabilitation or intercurrent illness. This improves the usefulness of any apparent change and keeps the patient goal visible across visits.

Apply the framework

A patient with HFpEF and obesity wants to attend family outings with less breathlessness. Record the present limitation, review the diagnosis and treatment plan, and discuss the relevant evidence. Choose a consistent way to reassess that outing related goal. Subsequent visits can then connect the patient's reported experience with clinical findings and the next shared decision.

Sources

  1. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Sources consulted October 6, 2026. Evidence interpretation and proposed exercises are identified in the text.

PURPOSE IN PRACTICE

Develop people while developing evidence.

The laboratory joins rigorous inquiry, distributed leadership, peer learning, transparent contribution, mentorship, and scholarly work that prepares future researchers to serve well.

Awaken the heartClarify purposeSteward giftsDevelop peopleMultiply influence